Literature DB >> 16024484

Physical complaints in ageing persons with spinal muscular atrophy.

Imelda J M de Groot1, Luc P de Witte.   

Abstract

OBJECTIVE: While life expectancy is improving for persons with spinal muscular atrophy, new physical complaints may arise. To investigate this, we studied persons with a long duration and severe course (high functional limitations) of the disease.
DESIGN: Cross-sectional descriptive study. SUBJECTS/PATIENTS: Persons with spinal muscular atrophy.
METHODS: Questionnaires and structured interviews on prevalence of physical complaints and their duration. Of 190 questionnaires 99 were returned; of 23 persons (with the longest disease duration and high functional limitation level) selected for structured medical interviews 9 participated.
RESULTS: Patterns common within and different between the different types of spinal muscular atrophy were identified. Of the 10 most common complaints, types 1-2 had a significantly higher prevalence of kyphoscoliosis, difficulty in coughing, joint contractures and voice/speech problems, while type 3 had a significantly higher prevalence of fatigue. No statistically significant correlation was found between the appearance of physical complaints and disease duration. However, sleeping and swallowing problems were in the 5 most common complaints with the shortest mean time of appearance. The structured interview revealed hypermobility in the hand, suffusion of the eyes, and itching as new complaints with high prevalence.
CONCLUSION: There are indications that the frequency of less well-known physical complaints increases with ageing.

Entities:  

Mesh:

Year:  2005        PMID: 16024484     DOI: 10.1080/16501970510030156

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  8 in total

1.  Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy.

Authors:  J Montes; M P McDermott; W B Martens; S Dunaway; A M Glanzman; S Riley; J Quigley; M J Montgomery; D Sproule; R Tawil; W K Chung; B T Darras; D C De Vivo; P Kaufmann; R S Finkel
Journal:  Neurology       Date:  2010-03-09       Impact factor: 9.910

2.  Amifampridine safety and efficacy in spinal muscular atrophy ambulatory patients: a randomized, placebo-controlled, crossover phase 2 trial.

Authors:  Silvia Bonanno; Riccardo Giossi; Riccardo Zanin; Valentina Porcelli; Claudio Iannacone; Giovanni Baranello; Gary Ingenito; Stanley Iyadurai; Zorica Stevic; Stojan Peric; Lorenzo Maggi
Journal:  J Neurol       Date:  2022-06-28       Impact factor: 6.682

3.  Fatigue in patients with spinal muscular atrophy type II and congenital myopathies: evaluation of the fatigue severity scale.

Authors:  Ulla Werlauff; A Højberg; R Firla-Holme; B F Steffensen; J Vissing
Journal:  Qual Life Res       Date:  2013-11-09       Impact factor: 4.147

Review 4.  Proximal spinal muscular atrophy: current orthopedic perspective.

Authors:  Gerrit Haaker; Albert Fujak
Journal:  Appl Clin Genet       Date:  2013-11-14

5.  Feeding and Swallowing Disorders in Pediatric Neuromuscular Diseases: An Overview.

Authors:  Lenie van den Engel-Hoek; Imelda J M de Groot; Bert J M de Swart; Corrie E Erasmus
Journal:  J Neuromuscul Dis       Date:  2015-11-20

6.  184th ENMC International Workshop: pain and fatigue in neuromuscular disorders: 20-22 May 2011, Naarden, The Netherlands.

Authors:  Imelda J M de Groot; Nicoline B M Voet; Henriët van Middendorp; Hans J A Knoop; Jes Rahbek; Baziel G M van Engelen
Journal:  Neuromuscul Disord       Date:  2013-08-07       Impact factor: 4.296

7.  Quantitative description of upper extremity function and activity of people with spinal muscular atrophy.

Authors:  Mariska M H P Janssen; Laura H C Peeters; Imelda J M de Groot
Journal:  J Neuroeng Rehabil       Date:  2020-09-11       Impact factor: 4.262

8.  An observational cohort study on impact, dimensions and outcome of perceived fatigue in adult 5q-spinal muscular atrophy patients receiving nusinersen treatment.

Authors:  Camilla Binz; Olivia Schreiber-Katz; Susanne Petri; Alma Osmanovic; Mareike Kumpe; Gresa Ranxha; Hannah Siegler; Gary Wieselmann
Journal:  J Neurol       Date:  2020-10-07       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.